0001415889-21-000886.txt : 20210223
0001415889-21-000886.hdr.sgml : 20210223
20210223182908
ACCESSION NUMBER: 0001415889-21-000886
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210219
FILED AS OF DATE: 20210223
DATE AS OF CHANGE: 20210223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BRYNELSEN CHARLES
CENTRAL INDEX KEY: 0001712459
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-02189
FILM NUMBER: 21667347
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABBOTT LABORATORIES
CENTRAL INDEX KEY: 0000001800
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 360698440
STATE OF INCORPORATION: IL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
BUSINESS PHONE: 2246676100
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
4
1
form4-02232021_030225.xml
X0306
4
2021-02-19
0000001800
ABBOTT LABORATORIES
ABT
0001712459
BRYNELSEN CHARLES
100 ABBOTT PARK ROAD
ABBOTT PARK
IL
60064
false
true
false
false
SENIOR VICE PRESIDENT
Common shares without par value
2021-02-19
4
A
0
7802
0
A
51612
D
Option (right to buy)
124.04
2021-02-19
4
A
0
39994
0
A
2022-02-19
2031-02-18
Common Shares
39994
39994
D
These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 13,331 on February 19, 2022, 13,331 on February 19, 2023, and 13,332 on February 19, 2024.
/s/ Charles Brynelsen by Jessica H. Paik, Attorney-in-Fact
2021-02-23